Search for Pharmacreams and
  1. April 7, 2014

    India’s Sun Pharma offers $3.2bn for ailing Ranbaxy

    Sun Pharmaceutical Industries has agreed to pay $3.2bn for the equity in Ranbaxy, the Indian generic drugmaker that has...

  2. April 4, 2014

    Meda: nothing to sneeze at

    Bless you! Investors in Meda might have said on Friday. News of an (albeit rejected) approach to the Swedish pharma company,...

  1. FT Tech Hub

    March 19, 2014

    IBM's Watson finds a new challenge: personalised cancer treatment

    For its most promising new technology, IBM has been searching for problems to solve that are both deep and broad enough....

  2. March 12, 2014

    Bayer: high hopes

    The 2014 targets from Bayer: 5 per cent sales growth; growth in earnings before interest, tax, depreciation and amortisation...

  3. October 22, 2013

    Reckitt paves way for £2bn pharma arm sale

    Reckitt Benckiser has paved the way for the possible sale of its pharmaceuticals arm, which it considers non-core to the...

  4. July 28, 2013

    Ireland’s ‘patent cliff’ poses problems for exit of bailout

    The metal reactors at Pfizer’s 200-acre manufacturing plant in Ringaskiddy that make the drug Viagra are not as busy as they...

  5. July 23, 2013

    Drug companies agree to release details of clinical studies

    European and US drug companies have agreed to share details of their clinical studies with independent researchers after...

  6. April 24, 2013

    GlaxoSmithKline: replacing lost energy

    GlaxoSmithKline is putting away childish things. The pharmaceuticals group’s decision to sell Lucozade and Ribena will cause...

  7. April 2, 2013

    AstraZeneca loses US drug patent judgment

    AstraZeneca’s portfolio of patent-protected drugs has been trimmed back after the pharmaceuticals group lost a legal...

  8. March 5, 2013

    Margins give the little guys a chance

    Margins are an issue of profound importance for any business. But how much scientific thinking is there on the subject? Are...

  9. February 25, 2013

    Reckitt Benckiser: motorcycle maintenance

    Like a motorcycle attached to a creaky sidecar, Reckitt Benckiser is being dragged back by something it does not really...

  10. February 25, 2013

    Ireland ripe for M&A surge, says report

    Ireland is ripe for a surge in mergers and acquisitions as its economy starts to recover, in spite of fears that the...

  11. January 31, 2013

    AstraZeneca warns of tough year ahead

    AstraZeneca’s new chief executive expressed openness to large, “disruptive” acquisitions, while stressing his primary focus...

  12. December 21, 2012

    Young entrepreneurs thrive in Myanmar

    At midnight on the roof terrace of The Street Bar & Restaurant in central Yangon, a DJ mixes rhythmic Myanmar rap with...

  13. December 6, 2012

    Court of Justice upholds AstraZeneca fine

    Europe’s highest court has upheld a €53m fine against AstraZeneca, in a closely watched case that penalised the...

  14. November 30, 2012

    ‘Tis the season to be wary as gifts roll in

    It’s that time of year again. The time of year when the in-trays of procurement managers, regulators, not to mention doctors...

  15. July 25, 2012

    GlaxoSmithKline – eurozoneitis

    The white coats at GlaxoSmithKline should start the hunt for a drug to cure the eurozone crisis. The pharmaceuticals group’s...

  16. June 29, 2012

    Moody’s sees negative ACA impact

    The pharmaceuticals industry gains certainty but will feel a greater financial squeeze as a result of the US Supreme Court’s...

  17. June 7, 2012

    Pfizer to spin off animal health business

    Pfizer, the world’s largest drug company by revenues, announced on Thursday that it would spin off its animal health...

  18. beyondbrics

    May 8, 2012

    Cipla's enlightened self-interest

    The man who battled big pharma is at it again. Yusuf Hamied was branded a “pirate” by some in the pharmaceuticals industry...

  19. May 7, 2012

    Drug uptake and pricing are crucial

    From Mr Stephen Whitehead. Sir, I read with interest John Gapper’s thoughts on the state of the pharmaceutical industry...

  20. May 2, 2012

    Pharma needs an injection of financial engineering

    “You’re going to need a bigger boat,” says the police chief played by Roy Scheider in the film Jaws, when he first catches...

  21. April 27, 2012

    Letter from Lex: Pharmachines

    Drugs and machines do not usually mix well, but the results in the pharma and TMT sectors this week were far from...

  22. April 10, 2012

    AstraZeneca

    The noise at AstraZeneca is the sound of knives being sharpened. The London-listed pharmaceuticals group’s shareholders are...

  23. March 22, 2012

    GSK announces plan to create 1,000 jobs

    GlaxoSmithKline provided swift endorsement for George Osborne’s Budget on Thursday by announcing plans to invest more than...

  24. March 11, 2012

    Hikma targets Turkish acquisition

    Hikma Pharmaceuticals has targeted Turkey as the next area for its global expansion plans, as the drug and injectables group...

  25. February 26, 2012

    Patent losses threaten Irish recovery

    Dublin’s export-led economic recovery will face a big challenge in coming months as several blockbuster drugs manufactured...

  26. February 22, 2012

    Wolters Kluwer in €100m share buy-back

    Wolters Kluwer, the Dutch professional information group, said it would buy back €100m of shares in 2012, as it tries to...

  27. FT Alphaville

    February 20, 2012

    Pfizer weighs plans for $3bn part-IPO

    The FT reports that Pfizer is weighing plans to raise about $3bn this year through a part-flotation of its animal health...

  28. FT Alphaville

    February 20, 2012

    Pfizer weighs plans for $3bn part-IPO

    Pfizer is weighing plans to raise about $3bn this year through a part-flotation of its animal health division, as the drugs...

  29. February 19, 2012

    Pfizer weighs plans for $3bn part-IPO

    Pfizer is weighing plans to raise about $3bn this year through a part-flotation of its animal health division, as the drugs...

  30. February 15, 2012

    European healthcare: Ailments encapsulated

    In the European Commission’s enterprise directorate in Brussels, offices have emptied in recent months as officials who once...

  31. February 8, 2012

    Reckitt to rejig global operations

    Reckitt Benckiser is merging its North American and European operations into a single business run out of Amsterdam in an...

  32. January 30, 2012

    US pharma: keep taking the tablets

    Time to get off the drugs? We’ve had a good time, after all. Over the past 12 months, the average return of the...

  33. January 8, 2012

    Bristol-Myers Squibb pays $2.5bn for Inhibitex

    Bristol-Myers Squibb, the pharmaceuticals group, has agreed to pay $2.5bn for Inhibitex, the smaller biopharmaceutical...

  34. December 28, 2011

    Abbott to finalise name change

    By Andrew Jack in London Abbott is finalising a new name for its pharmaceutical business, as it gears up to split into two...

  35. December 23, 2011

    J&J opts out of HIV rights sharing pool

    Johnson & Johnson has rejected calls to offer patent rights on its HIV medicines to generic drug companies through a “pool”...

  36. December 15, 2011

    Pharmaceutical giant gives new finance chief a soft landing

    From student days studying glaciers and urban agglomerations, Simon Dingemans now travels the world, guided by his...

  37. December 8, 2011

    Fall in funding to combat ‘neglected’ diseases

    Potential new treatments and vaccines for diseases including malaria and tuberculosis may never reach patients because of a...

  38. December 7, 2011

    AstraZeneca to cut 1,150 from US sales force

    AstraZeneca, the UK-based pharmaceuticals company, said on Wednesday it would cut nearly a quarter of its US sales force as...

Search for Pharmacreams and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Eli Lilly's John Lechleiter says pharma must reach out to inn...
    June 15, 2012

    Eli Lilly's John Lechleiter says pharma must reach out ...